Paitazoglou, C. Et Al. 2019. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. EUROINTERVENTION , vol.15, no.5 , 403-410.

Paitazoglou, C., ÖZDEMİR, R., Pfister, R., Bergmann, M. W., Bartunek, J., KILIÇ, T., ... Lauten, A.(2019). The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. EUROINTERVENTION , vol.15, no.5, 403-410.

Paitazoglou, Christina Et Al. "The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction," EUROINTERVENTION , vol.15, no.5, 403-410, 2019

Paitazoglou, Christina Et Al. "The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction." EUROINTERVENTION , vol.15, no.5, pp.403-410, 2019

Paitazoglou, C. Et Al. (2019) . "The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction." EUROINTERVENTION , vol.15, no.5, pp.403-410.

@article{article, author={Christina Paitazoglou Et Al. }, title={The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction}, journal={EUROINTERVENTION}, year=2019, pages={403-410} }